Chan, O., Ramlal, R., naqvi, S. M., Kim, J., Ali, N. A., Amisha, F., Sallman, D., Faramand, R., Khimani, F., Torres, N., Mishra, A., Mirza, A., Padron, E., Perez, L., Perna, F., Walker, A., Nishihori, T., Komrokji, R., Pidala, J., Lancet, J., Bejanyan, N. (2025). Outcomes of elderly (≥ 70) Acute Myeloid Leukemia (AML) patients receiving continued hypomethylating agent/venetoclax (HMA/VEN) versus allogeneic hematopoietic cell transplantation (HCT). Blood. https://doi.org/10.1182/blood-2025-4300